Skip to main content

Day: April 13, 2021

ION announces expiration and results of its Exchange Offer and Rights Offering

HOUSTON, April 13, 2021 (GLOBE NEWSWIRE) — ION Geophysical Corporation (NYSE: IO) (the “Company” or “ION”) today announced the expiration and results of its previously announced Exchange Offer and Rights Offering. In the Exchange Offer, approximately $113.5 million, or 94.1%, of the existing $120.6 million 9.125% Senior Secured Second Priority Notes due 2021 (the “Old Notes”) were tendered. The majority of the exchange consideration will be in the form of newly issued 8.00% Senior Secured Second Priority Notes due 2025 (the “New Notes”).   In the concurrent Rights Offering, shareholders exercised subscription rights totaling approximately $45 million, apportioned as approximately $32 million in New Notes and $13 million in ION Common Stock. All over-subscription rights will be exercised without proration as the $50 million limit...

Continue reading

First Commonwealth to Host First Quarter 2021 Earnings Conference Call on Wednesday, April 28, 2021

INDIANA, Pa., April 13, 2021 (GLOBE NEWSWIRE) — First Commonwealth Financial Corporation (NYSE: FCF) announced today that it will host a conference call on Wednesday, April 28, 2021 at 2:00 p.m. Eastern Time to discuss financial results for the quarter ended March 31, 2021. The call will be hosted by T. Michael Price, President and Chief Executive Officer. He will be joined by James R. Reske, Executive Vice President and Chief Financial Officer, Jane Grebenc, Executive Vice President and Chief Revenue Officer and Brian G. Karrip, Executive Vice President and Chief Credit Officer. First Commonwealth will issue a press release reporting its First Quarter 2021 financial results before the market opens on Tuesday, April 27, 2021. Conference Call InformationWhat: First Commonwealth Financial Corporation  First Quarter 2021 Earnings...

Continue reading

Capital Senior Living Completes Third Round of COVID-19 Vaccinations at All Communities and Reports March Occupancy

DALLAS, April 13, 2021 (GLOBE NEWSWIRE) — Capital Senior Living Corporation (the “Company”) (NYSE: CSU) has completed first, second and third rounds of COVID-19 vaccinations at all its communities. To date, 88% of residents are fully vaccinated with 90% of residents having received at least one dose of the COVID-19 vaccine. “We are very grateful that through our partnership with CVS Health, we have been able to administer no-cost, on-site vaccines to our employees and residents, and we are thrilled that so many of our residents are now fully vaccinated,” said Kimberly S. Lody, President and CEO. “The safety of our communities is always our top priority, and we believe the successful distribution of the vaccine is crucial to protecting residents and returning to normal daily activities. Now that our on-site clinics are complete, we...

Continue reading

Parkland Announces Closing of Senior Unsecured Notes Offering

CALGARY, Alberta, April 13, 2021 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) announced today the closing of its previously announced private offering (the “offering”) of US$800 million aggregate principal amount of 4.500% senior unsecured notes due 2029 (the “notes”). Parkland will use the net proceeds of the offering to redeem all of its 6.000% senior notes due 2026 in the aggregate principal amount of US$500 million, to redeem the remaining C$200 million of its 5.625% senior notes due 2025 in the aggregate principal amount of C$500 million not already called for redemption and repay certain amounts outstanding under its revolving bank credit facility. The notes were offered and sold only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of...

Continue reading

CARTESIAN GROWTH CORPORATION ANNOUNCES THE SEPARATE TRADING OF ITS CLASS A ORDINARY SHARES AND WARRANTS, COMMENCING APRIL 16, 2021

New York, NY , April 13, 2021 (GLOBE NEWSWIRE) — Cartesian Growth Corporation (the “Company”) announced today that, commencing Friday, April 16, 2021, holders of the units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s Class A ordinary shares and warrants included in the units. Any units not separated will continue to trade on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “GLBLU.”, and the Class A ordinary shares and warrants that are separated will trade on Nasdaq under the symbols “GLBL” and “GLBLW”, respectively. Each holder of units will need to have its broker contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into Class A ordinary shares and warrants. Registration statements relating...

Continue reading

COMPAGNIE LEBON : Opérations sur actions propres mars 2021

PROGRAMME DE RACHATDénomination sociale de l’Emetteur : LEBONLEI : 969500Q0TXUSFDLH3940 SIREN : 552018731Nature des titres (nom du titre + caractéristiques : ADP) :   ACTIONS Date de début du programme  27/05/2020TABLEAU DE DECLARATION MENSUELLE DES OPERATIONS REALISEESPAR UN EMETTEUR SUR SES PROPRES TITRES Opérations du mois Mars 2021I.              INFORMATIONS CUMULEESNombre de titres composant le capital de l’émetteur au début du programme 1 173 000Capital auto détenu de manière directe et indirecte au début du programme (en titres + %)  31 4052.68%   Solde à la fin du mois précédent 31 236   Nombre de titres achetés dans le mois          977Nombre de titres vendus dans le mois          905Nombre de titres transférés (1) dans le mois  0Nombre de titres annulés dans le mois : 0Rachat...

Continue reading

COMPAGNIE LEBON : Actions du capital et droit de vote au 31 mars 2021

Middle Office EmetteurTél. : 01 53 48 80 10 – Fax : 01 49 74 32 77 – 34318@cic.fr COMPAGNIE LEBONDate d’arrêté:31/03/2021ARTICLE 223-16 du règlement général de l’AMFActions du capital 1 173 000Droits de vote théoriques (1) 2 158 776Actions privées de droits de voteAutodétention au nominatif (2) 31 286Autodétention au porteur * (3) 0Autres * (4) 0* à compléter par la sociétéDroits de vote exerçables* 2 127 490*= (1) – [(2) + (3) + (4)]Pour information :Nombre de Comptes Courants Nominatifs 2 274 Pièce jointeDDV Compagnie Lebon 31 03 2021

Continue reading

Inventronics Announces 2020 Year End Financial Results

CALGARY, Alberta, April 13, 2021 (GLOBE NEWSWIRE) — Inventronics Limited (“Corporation”) (IVX:TSX Venture), a designer and manufacturer of custom enclosures for the telecommunications, electric transmission, cable television and other industries in North America, today announced its 2020 audited annual and unaudited 2020 Q4 financial results. For the year ended December 31, 2020, the Corporation reported net earnings of $684,000, or 15.5 cents per share, on revenue of $5,640,000 compared to net earnings of $195,000, or 4.4 cents per share, on revenue of $5,656,000 for the 2019 fiscal year. For the three months ended December 31, 2020, the Corporation reported a net loss of $15,000, or 0.4 cents per share, on revenue of $955,000 compared to a net loss of $151,000, or 3.5 cents per share, on revenue of $947,000, for the same period...

Continue reading

Euronet Worldwide Announces First Quarter 2021 Earnings Release Date and Conference Call Details

LEAWOOD, Kan., April 13, 2021 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (“Euronet” or the “Company”) (NASDAQ: EEFT) announced today it will release first quarter 2021 earnings results prior to the market opening on Thursday, April 29, 2021. Euronet will hold a conference call the same day at 9:00 a.m. Eastern Time to discuss the results. The conference call will be accessible via webcast by following the link posted on http://ir.euronetworldwide.com. Participants should go to the website at least five minutes prior to the scheduled start time of the event to register. A slideshow will be included in the webcast. The conference call will also be available by telephone by dialing 877-303-6313 (USA) or +1-631-813-4734 (non-USA). A webcast replay will be available beginning approximately one hour after the event at http://ir.euronetworldwide.com...

Continue reading

BIOPHYTIS Identifies False Report Regarding COVA study

PARIS and CAMBRIDGE, Mass., April 13, 2021 (GLOBE NEWSWIRE) — BIOPHYTIS SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, has been made aware of a false report regarding the status of its COVA study of its Sarconeos (BIO101) treatment in COVID-19 in Brazil. On April 12, 2021, an article was released via WBOC unbeknownst to BIOPHYTIS. The press release was misleading and released without BIOPHYTIS’ knowledge by unknown sources. BIOPHYTIS did not write, release nor approve this press release, on the subject of the COVA study...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.